Research Article
An Evaluation of Fluorouracil plus Paclitaxel and Oxiliplatin as a First-Line Treatment for Advanced Gastric Squamous Cell Carcinoma
Table 1
Comparison of general data between the two groups (
)/(
n(%)).
| | Study group (n = 87) | Control group (n = 81) | t/X2 | |
| | Age (years old) | 69.37 ± 3.58 | 70.28 ± 3.67 | 1.62 | 0.11 | | BMI (kg/m2) | 22.08 ± 2.04 | 22.24 ± 2.12 | 0.50 | 0.62 | | Gender | 0.04 | 0.83 | | Male | 54 (62.07) | 49 (60.49) | — | — | | Female | 33 (37.93) | 32 (39.51) | — | — | | Drinking history | 0.00 | 0.99 | | Yes | 59 (67.82) | 55 (67.90) | — | — | | No | 28 (32.18) | 26 (32.10) | — | — | | Smoking history | 0.07 | 0.79 | | Yes | 53 (60.92) | 51 (62.96) | — | — | | No | 34 (39.08) | 30 (37.04) | — | — | | IIIb | 15 (17.24) | 12 (14.81) | 0.18 | 0.67 | | IV | 72 (82.76) | 69 (85.19) | — | — | | Initial treatment | 32 (36.78) | 28 (34.57) | 0.09 | 0.76 | | Retreatment | 55 (63.22) | 53 (65.43) | — | — |
|
|
